Document is current
Any future updates will be listed below
-
Authors
Zhang, Yuan
Shan, Chunguang
Liu, Weiwei
Han, Yaozhong
Shi, Guanggang
Ma, Yongjian
Wagner, Kerstin
Tian, Xiaoyan
Zhang, Lili
Larona, Allan Joseph
Sacavage, Steven
Franklin, Kathleen
Wang, Chengshuo
Zhang, Luo https://orcid.org/0000-0002-0910-9884
-
Funding
Funding for this research was provided by:
Johnson and Johnson Pharmaceutical Research and Development
- License Information
-
More Information
Article History
Received: 16 November 2021
Accepted: 17 May 2022
First Online: 20 June 2022
Declarations
:
: The protocol and amendment were approved by the medical ethics committee of Beijing Tongren Hospital, The No.2 Hospital of Baoding, Cangzhou Center Hospital, The Second Hospital to Hebei Medical University, Shandong Provincial Hospital, and The No.2 People’s Hospital of Weifang. Prior to enrollment, all subjects provided written informed consent. The study was registered at (NCT04132570).
: Not applicable.
: YZ, CS, WL, YH, GS, YM, CW, and LZ are investigators for the clinical trial. KW, XT, LiliZ, AJL, SS, and KF are employees of the Johnson & Johnson Family of Consumer Companies.
